ES390873A1 - Un procedimiento de cultivo de virus. - Google Patents

Un procedimiento de cultivo de virus.

Info

Publication number
ES390873A1
ES390873A1 ES390873A ES390873A ES390873A1 ES 390873 A1 ES390873 A1 ES 390873A1 ES 390873 A ES390873 A ES 390873A ES 390873 A ES390873 A ES 390873A ES 390873 A1 ES390873 A1 ES 390873A1
Authority
ES
Spain
Prior art keywords
virus
cell
cells
culture
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES390873A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Publication of ES390873A1 publication Critical patent/ES390873A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18161—Methods of inactivation or attenuation
    • C12N2760/18164—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES390873A 1970-05-11 1971-05-05 Un procedimiento de cultivo de virus. Expired ES390873A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707017053A FR2088038B1 (cs) 1970-05-11 1970-05-11

Publications (1)

Publication Number Publication Date
ES390873A1 true ES390873A1 (es) 1975-03-16

Family

ID=9055329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES390873A Expired ES390873A1 (es) 1970-05-11 1971-05-05 Un procedimiento de cultivo de virus.

Country Status (12)

Country Link
BE (1) BE766442A (cs)
CH (1) CH532659A (cs)
CS (1) CS178080B2 (cs)
DE (1) DE2121237C3 (cs)
DK (1) DK129468B (cs)
ES (1) ES390873A1 (cs)
FR (1) FR2088038B1 (cs)
GB (1) GB1338043A (cs)
HU (1) HU165705B (cs)
NL (1) NL7106379A (cs)
PL (1) PL88908B1 (cs)
RO (1) RO62179A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801601A (nl) * 1988-06-23 1990-01-16 Centraal Diergeneeskundig Inst Een "swine-kidney" celcultuur, geschikt voor het kweken van virussen, een daaraan geadapteerde "chinese" stam van het varkenspestvirus, alsmede de hiervan afgeleide vaccins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299514A (fr) * 1960-11-25 1962-07-27 Bayer Ag Procédé de reproduction du virus de la fièvre aphteuse
DE1174016B (de) * 1962-05-18 1964-07-16 Behringwerke Ag Verfahren zur Herstellung einer Lebend-Vaccine gegen Maul- und Klauenseuche

Also Published As

Publication number Publication date
FR2088038A1 (cs) 1972-01-07
HU165705B (cs) 1974-10-28
NL7106379A (cs) 1971-11-15
PL88908B1 (cs) 1976-10-30
FR2088038B1 (cs) 1973-08-10
BE766442A (fr) 1971-09-16
DK129468B (da) 1974-10-14
DE2121237A1 (de) 1971-12-02
GB1338043A (en) 1973-11-21
DE2121237C3 (de) 1980-03-06
RO62179A (cs) 1977-05-15
CS178080B2 (cs) 1977-08-31
DK129468C (cs) 1975-03-03
DE2121237B2 (de) 1979-07-05
CH532659A (fr) 1973-01-15

Similar Documents

Publication Publication Date Title
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
ATE7855T1 (de) Herstellung von virusantigenen.
ES8404186A1 (es) "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b".
ATE301707T1 (de) Aus einer mit einem stamm von multiple-sklerosis- virus infizierten zellinie hergestelltes biologisches virusmaterial
GB1121308A (en) Cephalosporins
ES405471A1 (es) Un procedimiento para la preparacion de un enzima.
ES333922A1 (es) Un procedimiento para la preparacion de una enzima coaguladora de la leche.
ES390873A1 (es) Un procedimiento de cultivo de virus.
IE47060B1 (en) Process for the cultivation of viruses
GB1488800A (en) Influenza vaccines
GB1303560A (cs)
Band Biotin, a growth requirement for four soil amoebae
GB1276218A (en) Calf diarrhea virus vaccine and processes
GB811411A (en) Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom
Hozumi et al. Spontaneous reduction of transplantability in cultured mammary carcinoma cells
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
GB981273A (en) A method for preparing 5-keto fructose by fermentation
SU124911A2 (ru) Способ энзиматического осветлени плодо годных вин при брожении
ES449582A1 (es) Procedimiento para la produccion de s 31794nf-1.
FR2150799A1 (en) Equine infectious anaemia - prepn of immunising vaccine
GB1420713A (en) Process for the preparation of immuno-suppressive antihuman lymphocyte sera
ES446396A1 (es) Procedimiento para preparar vacunas estimulantes de la pro- duccion de anticuerpos contra virus.
ES8205064A1 (es) Un procedimiento para regular la marcha de motores de cual- quier naturaleza
ES405090A1 (es) Procedimiento para la produccion de acido citrico.
GB992330A (en) Hog cholera serum